cms glp 1 coverage Issues Guidance on GLP-1 Anti-Obesity Drugs Big changes may be coming

If you experience significant pain, swelling, or persistent irritation, discontinue use and contact your provider

Understanding your genetic predispositions in peptide metabolismalongside clinical labs (fasting glucose, insulin, HbA1c), BMI, comorbidities, and medication historycan support a more informed, personalized conversation with your provider about whether berberine, compounded GLP-1 agonists (semaglutide or tirzepatide), or a combination approach best supports your health goals and unique physiology

L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitisa randomized and controlled clinical trial

Influenza, norovirus, and other viral infections can affect multiple family members over a short period of timeoften leading to cumulative fatigue, dehydration, and prolonged recovery

autoimmunity reviews

In vitro studies, HepG2 cells treated with palmitic acid (PA) were found that dulaglutide significantly reduced liver lipid accumulation and gene expression related to lipid drop-binding proteins, de novo adipogenesis and TG synthesis